MedPath

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

Active, not recruiting
Conditions
Faecal Incontinence
Prostate Cancer
Registration Number
NCT04262609
Lead Sponsor
Consorci Sanitari de Terrassa
Brief Summary

The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.

Detailed Description

The investigators know that high doses of irradiation in the anal sphincter are associated with more chronic fecal leaks in survivors irradiated by normofractionated radiotherapy prostate cancer.

The safe dose of irradiation of the anal sphincter with radiotherapy modern techniques (volumetric modulated arc therapy with moderately hypofracctionation) is unknown.

Urgency and faecal incontinence greatly affects the quality of life of these patients.

Therefore, it is interesting to implement strategies to protect the anatomical structures involved in fecal continence.

The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with modern moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.

The investigators also want to evaluate the quality of life of these patients

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
200
Inclusion Criteria
  • Prostate cancer survivors treated in our department by hypofractionated radiotherapy
Exclusion Criteria
  • Relapse of prostate cancer
  • Other active cancer
  • Mental disorder

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
faecal incontinence after prostate radiation therapychange 5 years after completion of radiotherapy

grade of faecal incontinence in prostate cancer survivors

Secondary Outcome Measures
NameTimeMethod
Quality of life after prostate radiation therapy5 years after completion of radiotherapy

Quality of life in prostate cancer survivors comparing continents patients and incontinents patients

Trial Locations

Locations (1)

Consorci Sanitari de Terrassa

🇪🇸

Terrassa, Catalonia, Spain

© Copyright 2025. All Rights Reserved by MedPath